Canopy Growth Corp. (WEED:CA) (CGC)
On June 3, 2025, ATB Capital Markets significantly revised its outlook on Canopy Growth Corp., lowering its 12-month price target from CAD 3.20 to CAD 1.60—a 50% reduction. Alongside the target cut, the firm maintained its “Underperform” rating, signaling continued concern about the company’s near-term prospects and relative performance compared to peers.
Stock Forecast & Analysis
Analyst sentiment toward Canopy Growth Corp. remains broadly negative, reflecting a company struggling to regain investor confidence amid worsening fundamentals and a challenged cannabis sector.
According to data from five analysts, the average 12-month target price is CAD 3.87, suggesting a potential upside from the current price—but this average is somewhat skewed by outdated and more optimistic forecasts, as recent analyst updates show rapidly diminishing expectations. Importantly, the average analyst rating is “Underperform”, a clear indication that most analysts believe the stock will lag the market and its sector peers in the year ahead.
Stock Target Advisor’s analysis shows has a “Very Bearish” analysis and rating on Canopy Growth, based on a quantitative model that found 0 positive signals and 5 negative signals. These negative indicators likely include:
Recent Stock Performance:
Past Week |
-28.51% |
Past Month |
-9.19% |
Past Year |
-84.27% |
Last Close |
CAD 1.68 |
Canopy’s share price is now down over 84% year-over-year, a staggering collapse that reflects both internal execution issues and the broader contraction in the cannabis equity space. The recent 28% drop in just a week highlights how fragile sentiment has become, with investors reacting strongly to any negative news or downgrades.
Outlook
Canopy Growth Corp remains in a precarious position, with analysts and quantitative models aligned in their bearish outlook. Despite the apparent gap between the current price (CAD 1.68) and the average analyst target (CAD 3.87), the reality is that most updated targets are well below that average. Investors should approach with caution, as the company continues to face liquidity pressures, weak fundamentals, and an oversupplied, price-pressured cannabis market.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
